Tissue-based research in kidney cancer: current challenges and future directions

Clinical Cancer Research

Volumn 14, Issue 12, 2008, Pages 3699-3705

  Signoretti, Sabina ^a   Bratslavsky, Gennady ^d   Waldman, Frederick M ^f   Reuter, Victor E ^g   Haaga, John ^h   Merino, Maria ^e   Thomas, George V ⁱ   Pins, Michael R ^j   Libermann, Towia ^b   Gillespie, John ^k   Tomaszewski, Joseph E ^l   Compton, Carolyn C ^d   Hruszkewycz, Andrew ^d   Linehan, W Marston ^d   Atkins, Michael B ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BIDMC Genomics Center   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Laboratory of Pathology   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^k SAIC FREDERICK INC   (United States)

^l NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PARAFFIN; TUMOR MARKER;

ANALYTIC METHOD; CANCER RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGING; KIDNEY CANCER; KIDNEY PARENCHYMA; MOLECULAR MECHANICS; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; REVIEW; TISSUE MICROARRAY; TISSUE PREPARATION; TISSUE PRESERVATION; TUMOR BIOPSY; ALGORITHM; BIOLOGICAL MODEL; COMPUTER ASSISTED SURGERY; DRUG SCREENING; EVALUATION; GENETICS; GENOMICS; HEALTH CARE FACILITY; KIDNEY CARCINOMA; KIDNEY TUMOR; METHODOLOGY; PATHOLOGY; TRANSPLANTATION;

ALGORITHMS; CARCINOMA, RENAL CELL; DRUG EVALUATION, PRECLINICAL; GENOMICS; HUMANS; KIDNEY NEOPLASMS; MODELS, BIOLOGICAL; PARAFFIN EMBEDDING; QUALITY CONTROL; RESEARCH DESIGN; SURGERY, COMPUTER-ASSISTED; TISSUE AND ORGAN HARVESTING; TISSUE BANKS; TUMOR MARKERS, BIOLOGICAL;

EID: 52449083473     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4733     Document Type: Review

References (27)

1. Atkins MB, Ernstoff MS, Figlin RA, et al. Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin Cancer Res 2007;13:667-70s.
2. Brugarolas J. Renal-cell carcinoma-molecular pathways and therapies. N Engl J Med 2007;356:185-7.
3. Lechevallier E, Andre M, Barriol D, et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 2000;216:506-10.
4. Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol 2003;180:1281-7.
5. Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007;178:379-86.
6. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006;49:798-805.
7. Kaklamani V. A genetic signature can predict prognosis and response to therapy in breast cancer: Onco-type DX. Expert Rev Mol Diagn 2006;6:803-9.
8. Reuter VE. The pathology of renal epithelial neoplasms. Semin Oncol 2006;33:534-43.
9. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006;175:425-31.
10. Giltnane JM, Rimm DL Technology insight: Identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 2004;1:104-11.
11. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63
12. Atkins M, Regan M, McDermott D, et al. Carbonic anhydrase IX expression predicts outcome of interleu-kin 2 therapy for renal cancer. Clin Cancer Res 2005;11:3714-21.
13. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
14. DiVito KA, Charette LA, Rimm DL, Camp RL. Long-term preservation of antigenicity on tissue micro-arrays. Lab Invest 2004;84:1071-8.
15. Feldman DR, Motzer RJ. Novel targets and therapies for metastatic renal cell carcinoma. Oncology (Huntingt) 2006;20:1745-53; discussion 1756.
16. Patel PH, Chadalavada RS, Chaganti RS, Motzer RJ. Targeting von Hippel-Lindau pathway in renal cell carcinoma. Clin Cancer Res 2006;12:7215-20.
17. Hudes G, Carducci M.Tomczak P, et al.Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356:2271-81.
18. Hampton T Trials probe new agents for kidney cancer. JAMA 2006;296:155-7.
19. Cho D, Signoretti S, Regan M, Mier JW, Atkins MB. The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer. Clin Cancer Res 2007;13:758-63s.
20. Thomas GV.Tran C, Mellinghoff IK, et al. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 2006;12:122-7.
21. Cho D, Signoretti S, Dabora S, et al. Potential histologic and molecular predictors of response to temsiro-limus in patients with advanced renal cell carcinoma. Clin Genitourin Cancer 2007;5:379-85.
22. Rini Bl, Jaeger E, Weinberg V, et al. Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. BJU Int 2006;98:756-62.
23. Jones J, LibermannTA. Genomics of renal cell cancer: the biology behind and the therapy ahead. Clin Cancer Res 2007;13:685-92s.
24. Jones J, Otu H, Spentzos D, et al. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 2005;11:5730-9.
25. Motzer RJ, Bacik J, Mazumdar M. Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience. Clin Cancer Res 2004;10:6302-3S.
26. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477-90.
27. Micke P, Ohshima M, Tahmasebpoor S, et al. Bio-banking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest 2006;86:202-11.